HBV-related hepatocellular carcinoma: A call to improve surveillance and linkage to care

In our recent multi-center study, we found that non-Asians with hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) were more likely to present with decompensated and advanced disease compared with Asians 1 . However, non-Asians were more likely to undergo curative HCC treatment versus Asians. Among patients without cirrhosis, non-Asians had a poorer 5-year survival versus Asians (38% versus 54%). The letter from Dr Jia and colleagues raises some points that merit discussion 2 .